Beta-blockers in septic shock to optimize hemodynamics? We are not sure

Affiliations

¹ Department of Intensive Care, CHIREC Hospitals, Université Libre de Bruxelles, Rue Wayez 35, 1420, Braine l'Alleud, Brussels, Belgium. ddebacke@ulb.ac.be.
² General Intensive Care Unit, Raymond Poincaré Hospital (APHP), Laboratory of Infection and Inflammation, U1173 INSERM and University of Versailles SQY, 104 Boulevard Raymond Poincaré, 92380, Garches, France.

Editorial

Daniel De Backer et al. Intensive Care Med. 2016 Oct.

. 2016 Oct;42(10):1613-1614.

doi: 10.1007/s00134-016-4421-5. Epub 2016 Jun 27.

¹ Department of Intensive Care, CHIREC Hospitals, Université Libre de Bruxelles, Rue Wayez 35, 1420, Braine l'Alleud, Brussels, Belgium. ddebacke@ulb.ac.be.
² General Intensive Care Unit, Raymond Poincaré Hospital (APHP), Laboratory of Infection and Inflammation, U1173 INSERM and University of Versailles SQY, 104 Boulevard Raymond Poincaré, 92380, Garches, France.

No abstract available

Comment on

Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial.
Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, Orecchioni A, D'Egidio A, D'Ippoliti F, Raffone C, Venditti M, Guarracino F, Girardis M, Tritapepe L, Pietropaoli P, Mebazaa A, Singer M. Morelli A, et al. JAMA. 2013 Oct 23;310(16):1683-91. doi: 10.1001/jama.2013.278477. JAMA. 2013. PMID: 24108526 Clinical Trial.